See more : ARIAKE JAPAN Co., Ltd. (AKEJF) Income Statement Analysis – Financial Results
Complete financial analysis of Pharma Foods International Co., Ltd. (2929.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pharma Foods International Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Design Capital Limited (1545.HK) Income Statement Analysis – Financial Results
- Fabrinet (FN) Income Statement Analysis – Financial Results
- Walgreens Boots Alliance, Inc. (WBA) Income Statement Analysis – Financial Results
- TransCanna Holdings Inc. (TCAN.CN) Income Statement Analysis – Financial Results
- Yee Hop Holdings Limited (1662.HK) Income Statement Analysis – Financial Results
Pharma Foods International Co., Ltd. (2929.T)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.pharmafoods.co.jp
About Pharma Foods International Co., Ltd.
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. Its products include Pharma-GABA, Bonepep, Ovopron (egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid. Pharma Foods International Co., Ltd. has licensing agreement with Mitsubishi Tanabe Pharma Corporation for a new therapeutic antibody to treat autoimmune diseases. Pharma Foods International Co., Ltd. was founded in 1997 and is based in Kyoto, Japan.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 62.15B | 68.57B | 60.19B | 46.75B | 15.35B | 10.53B | 7.94B | 4.72B | 3.46B | 2.17B | 1.61B | 1.52B | 1.23B | 1.01B | 959.10M | 734.10M | 810.84M |
| Cost of Revenue | 13.40B | 13.29B | 12.08B | 7.03B | 3.18B | 2.00B | 1.59B | 1.01B | 1.00B | 787.35M | 712.19M | 630.92M | 658.31M | 589.25M | 515.86M | 488.90M | 534.76M |
| Gross Profit | 48.75B | 55.28B | 48.11B | 39.73B | 12.18B | 8.54B | 6.35B | 3.72B | 2.46B | 1.38B | 902.37M | 893.59M | 566.72M | 417.41M | 443.24M | 245.19M | 276.08M |
| Gross Profit Ratio | 78.45% | 80.61% | 79.93% | 84.97% | 79.30% | 81.05% | 79.96% | 78.69% | 71.05% | 63.64% | 55.89% | 58.61% | 46.26% | 41.47% | 46.21% | 33.40% | 34.05% |
| Research & Development | 978.00M | 840.00M | 766.00M | 522.00M | 437.68M | 317.16M | 274.24M | 241.98M | 313.24M | 243.57M | 199.75M | 172.00M | 172.70M | 133.96M | 164.38M | 174.60M | 224.15M |
| General & Administrative | 11.77B | 4.10B | 3.41B | 2.75B | 975.86M | 755.79M | 473.12M | 482.05M | 357.99M | 380.02M | 254.31M | 24.68M | 16.98M | 17.65M | 20.28M | 109.85M | 204.09M |
| Selling & Marketing | 30.79B | 38.87B | 35.75B | 24.86B | 7.38B | 4.93B | 3.64B | 1.77B | 1.19B | 790.07M | 223.13M | 82.69M | 64.95M | 58.46M | 61.72M | 0.00 | 0.00 |
| SG&A | 42.56B | 42.96B | 39.16B | 27.61B | 8.35B | 5.68B | 4.11B | 2.26B | 1.55B | 1.17B | 477.44M | 107.37M | 81.93M | 76.11M | 82.00M | 109.85M | 204.09M |
| Other Expenses | 100.00M | 89.00M | 7.10B | 5.91B | 2.65B | 1.96B | 41.06M | 42.39M | 78.88M | 39.66M | 21.72M | 19.05M | 45.29M | 61.05M | 64.16M | 53.83M | 53.43M |
| Operating Expenses | 43.64B | 51.67B | 47.03B | 34.05B | 11.44B | 7.96B | 6.05B | 2.52B | 1.86B | 1.56B | 802.17M | 472.79M | 408.69M | 377.70M | 431.63M | 423.82M | 602.81M |
| Cost & Expenses | 57.03B | 64.96B | 59.10B | 41.08B | 14.61B | 9.96B | 7.65B | 3.52B | 2.86B | 2.35B | 1.51B | 1.10B | 1.07B | 966.95M | 947.49M | 912.73M | 1.14B |
| Interest Income | 1.00M | 1.00M | 2.00M | 3.00M | 4.39M | 5.56M | 7.17M | 8.71M | 10.69M | 10.30M | 10.33M | 7.25M | 16.52M | 21.94M | 18.61M | 15.27M | 0.00 |
| Interest Expense | 62.00M | 48.00M | 26.00M | 12.00M | 8.49M | 7.36M | 5.04M | 5.40M | 4.14M | 79.00K | 802.00K | 1.24M | 845.00K | 163.00K | 667.00K | 1.18M | 1.79M |
| Depreciation & Amortization | 907.00M | 546.00M | 520.00M | 181.00M | 151.85M | 91.53M | 89.14M | 76.16M | 43.37M | 30.30M | 24.87M | 24.76M | 25.42M | 32.74M | 40.63M | 48.49M | 61.53M |
| EBITDA | 6.00B | 4.16B | 1.60B | 5.86B | 1.01B | 767.47M | 407.84M | 205.43M | 76.22M | -153.90M | 37.36M | 319.49M | 91.91M | -9.38M | 60.47M | -155.00M | -380.00M |
| EBITDA Ratio | 9.66% | 6.12% | 3.01% | 12.75% | 6.18% | 6.94% | 5.71% | 28.25% | 20.82% | -3.51% | 10.27% | 35.45% | 19.28% | 14.83% | 14.08% | -8.78% | -27.39% |
| Operating Income | 5.11B | 3.61B | 1.08B | 5.67B | 740.02M | 576.25M | 296.43M | 89.44M | -46.35M | -371.85M | -28.13M | 217.06M | 70.78M | -44.28M | -63.95M | -264.17M | -452.31M |
| Operating Income Ratio | 8.23% | 5.26% | 1.79% | 12.13% | 4.82% | 5.47% | 3.73% | 1.89% | -1.34% | -17.17% | -1.74% | 14.24% | 5.78% | -4.40% | -6.67% | -35.99% | -55.78% |
| Total Other Income/Expenses | -79.00M | -68.00M | 343.00M | 92.00M | 107.00M | 92.33M | 17.22M | 34.44M | 75.06M | 187.36M | 39.82M | 76.43M | -5.13M | 2.00M | 83.12M | 60.03M | 9.48M |
| Income Before Tax | 5.03B | 3.54B | 1.42B | 5.77B | 848.65M | 668.58M | 313.65M | 123.87M | 28.71M | -184.50M | 11.69M | 293.49M | 65.64M | -42.28M | 19.17M | -204.14M | -442.84M |
| Income Before Tax Ratio | 8.10% | 5.17% | 2.36% | 12.33% | 5.53% | 6.35% | 3.95% | 2.62% | 0.83% | -8.52% | 0.72% | 19.25% | 5.36% | -4.20% | 2.00% | -27.81% | -54.61% |
| Income Tax Expense | 1.83B | 462.00M | 1.80B | 1.92B | 157.71M | 160.77M | -8.86M | 18.58M | 2.41M | 3.39M | 2.86M | 24.14M | 5.61M | 4.32M | 3.93M | 3.44M | 12.18M |
| Net Income | 3.21B | 3.08B | -374.00M | 3.84B | 690.00M | 499.85M | 313.66M | 101.31M | 25.90M | -187.89M | 8.83M | 269.35M | 60.03M | -46.60M | 15.25M | -207.58M | -455.02M |
| Net Income Ratio | 5.16% | 4.49% | -0.62% | 8.22% | 4.49% | 4.75% | 3.95% | 2.15% | 0.75% | -8.68% | 0.55% | 17.67% | 4.90% | -4.63% | 1.59% | -28.28% | -56.12% |
| EPS | 112.69 | 106.70 | -12.89 | 132.21 | 23.79 | 17.21 | 10.80 | 3.49 | 0.89 | -6.49 | 0.34 | 11.46 | 2.56 | -1.98 | 0.65 | -8.83 | -19.36 |
| EPS Diluted | 112.69 | 106.70 | -12.89 | 132.14 | 23.78 | 17.21 | 10.80 | 3.49 | 0.89 | -6.49 | 0.34 | 11.45 | 2.55 | -1.98 | 0.65 | -8.83 | -19.36 |
| Weighted Avg Shares Out | 28.44M | 28.88M | 29.01M | 29.05M | 29.04M | 29.04M | 29.03M | 29.03M | 29.03M | 28.97M | 25.92M | 23.50M | 23.50M | 23.50M | 23.50M | 23.50M | 23.50M |
| Weighted Avg Shares Out (Dil) | 28.44M | 28.88M | 29.01M | 29.07M | 29.05M | 29.04M | 29.03M | 29.03M | 29.03M | 28.97M | 25.92M | 23.52M | 23.54M | 23.50M | 23.54M | 23.50M | 23.50M |
Source: https://incomestatements.info
Category: Stock Reports